Aprea Therapeutics (APRE)
(Delayed Data from NSDQ)
$3.30 USD
+0.08 (2.48%)
Updated Aug 13, 2024 03:41 PM ET
After-Market: $3.34 +0.04 (1.21%) 6:46 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-0.65 | 0.00% |
Earnings Summary
For their last quarter, Aprea Therapeutics (APRE) reported earnings of -$0.58 per share, beating the Zacks Consensus Estimate of $-0.64 per share. This reflects a positive earnings surprise of 9.38%. Look out for APRE's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$0.65 per share, reflecting a year-over-year increase of 24.42%.
Earnings History
Price & Consensus
Zacks News for APRE
Liquidia Technologies, Inc. (LQDA) Reports Q2 Loss, Lags Revenue Estimates
APRE: What are Zacks experts saying now?
Zacks Private Portfolio Services